Hepatitis C

Increasing access to hepatitis C care through drugs services

People who inject drugs are a key population for the elimination of hepatitis C in Europe; increasing access to HCV testing and care for this group is a goal in European and national hepatitis C policies. This EMCDDA Harm Reduction initiative provides a set of new materials and tools to help countries to analyse barriers to testing at drug services, to identify solutions in collaboration with all stakeholders involved and to implement new models of care in this field.